Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4789350
Max Phase: Preclinical
Molecular Formula: C19H22N2O2
Molecular Weight: 310.40
Molecule Type: Unknown
Associated Items:
ID: ALA4789350
Max Phase: Preclinical
Molecular Formula: C19H22N2O2
Molecular Weight: 310.40
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1nc2ccc(Oc3ccc(O)c(C(C)(C)C)c3)cc2n1C
Standard InChI: InChI=1S/C19H22N2O2/c1-12-20-16-8-6-14(11-17(16)21(12)5)23-13-7-9-18(22)15(10-13)19(2,3)4/h6-11,22H,1-5H3
Standard InChI Key: LQWRSCHPPDJXLC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 310.40 | Molecular Weight (Monoisotopic): 310.1681 | AlogP: 4.68 | #Rotatable Bonds: 2 |
Polar Surface Area: 47.28 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.33 | CX Basic pKa: 6.15 | CX LogP: 4.35 | CX LogD: 4.32 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.75 | Np Likeness Score: -0.59 |
1. Shinozuka T,Ito S,Kimura T,Izumi M,Wakabayashi K. (2021) Discovery of a Novel Class of ERRα Agonists., 12 (5.0): [PMID:34055231] [10.1021/acsmedchemlett.1c00100] |
Source(1):